(19)
(11) EP 4 798 231 A1

(12)

(43) Date of publication:
02.09.2026 Bulletin 2026/36

(21) Application number: 24883386.5

(22) Date of filing: 25.10.2024
(51) International Patent Classification (IPC): 
A61K 39/00(2006.01)
A61K 38/17(2006.01)
C12N 15/85(2006.01)
C07K 14/705(2006.01)
C07K 7/06(2006.01)
A61P 35/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 35/00; A61K 40/11; C07K 14/4748; G01N 33/56977; G01N 33/505; G01N 2800/52; A61K 40/32; A61K 40/4268; A61K 39/0011; A61K 2039/572; G01N 33/57557
(86) International application number:
PCT/US2024/052934
(87) International publication number:
WO 2025/090850 (01.05.2025 Gazette 2025/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 27.10.2023 US 202363546105 P
16.02.2024 US 202463554734 P

(71) Applicant: Tscan Therapeutics, Inc.
Waltham, MA 02451 (US)

(72) Inventors:
  • NABILSI, Nancy
    Waltham, MA 02451 (US)
  • TADROS, Jenny
    Waltham, MA 02451 (US)
  • JUREWICZ, Mollie, M.
    Waltham, MA 02451 (US)
  • MACBEATH, Gavin
    Waltham, MA 02451 (US)

(74) Representative: Leonard, Thomas Charles et al
Kilburn & Strode LLP Lacon London 84 Theobalds Road
London WC1X 8NL
London WC1X 8NL (GB)

   


(54) MAGEA1 IMMUNOGENIC PEPTIDES, BINDING PROTEINS RECOGNIZING MAGEA1 IMMUNOGENIC PEPTIDES, AND USES THEREOF